Literature DB >> 17319837

Transfusion-acquired Trypanosoma cruzi infection.

Carolyn Young1, Phyllis Losikoff, Anjulika Chawla, Lewis Glasser, Edwin Forman.   

Abstract

BACKGROUND: A 3(1/2)-year-old girl with Stage 4 neuroblastoma received multiple blood components and was subsequently diagnosed with Chagas disease, which is caused by Trypanosoma cruzi. STUDY DESIGN AND METHODS: All blood donors of the units that were transfused were requested to return to the collection facility for a blood sample to be tested for antibodies to T. cruzi.
RESULTS: One first-time donor was found to be positive for the presence of T. cruzi antibodies. This donor was originally from Bolivia and immigrated to the United States 17 years previously. She had not returned to her native country since her emigration.
CONCLUSIONS: This is the seventh reported case of Chagas disease transmission by blood transfusion in the United States and Canada. Although this would not be expected to occur in New England, it did, and this case demonstrates the significance of the immune status of patients as it relates to transfusion-acquired infections, the impact of geographic mobility in disease transmission, and the need for a licensed screening test for Chagas disease for the US blood supply.

Entities:  

Mesh:

Year:  2007        PMID: 17319837     DOI: 10.1111/j.1537-2995.2006.01147.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  29 in total

1.  Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera.

Authors:  Cristina Riera; Mireia Verges; Laura Iniesta; Roser Fisa; Montserrat Gállego; Silvia Tebar; Montserrat Portús
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 3.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

4.  Diagnosis of Trypanosoma cruzi Infection Status using Saliva of Infected Subjects.

Authors:  Nuria Cortes-Serra; Maria-Jesus Pinazo; Leonardo de la Torre; Melina Galizzi; Joaquim Gascon; Juan Manuel Bustamante
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

5.  The emergence of chagas disease in the United States and Canada.

Authors:  Louis V Kirchhoff; Richard D Pearson
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

Review 6.  Kinetoplastids: related protozoan pathogens, different diseases.

Authors:  Ken Stuart; Reto Brun; Simon Croft; Alan Fairlamb; Ricardo E Gürtler; Jim McKerrow; Steve Reed; Rick Tarleton
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 7.  Transmission and epidemiology of zoonotic protozoal diseases of companion animals.

Authors:  Kevin J Esch; Christine A Petersen
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

8.  Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.

Authors:  Christoph Niederhauser; Jochen Gottschalk; Caroline Tinguely
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

9.  Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  Vaccine       Date:  2012-10-15       Impact factor: 3.641

10.  2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi.

Authors:  Enrique I Ramos; Kristine M Garza; R L Krauth-Siegel; Julia Bader; Luiz E Martinez; Rosa A Maldonado
Journal:  J Parasitol       Date:  2009-04       Impact factor: 1.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.